Overview

Real-time Margin Assessment in Head and Neck Cancer

Status:
Not yet recruiting
Trial end date:
2025-01-10
Target enrollment:
Participant gender:
Summary
To investigate if the combination of fresh frozen sectioning based on cetuximab-800CW can enhance tumor-positive margin detection intra-operatively.
Phase:
Phase 2
Details
Lead Sponsor:
University Medical Center Groningen
Treatments:
Cetuximab